All posts by imreal

ER Injury Attorneys Sponsor Candlelighters’ Superhero 5K in Las Vegas


ER Injury Attorneys - Sponsors 2022 Superhero 5K

ER Injury Attorneys – Sponsors of 2022 Superhero 5K

One of the highest priorities of ER Injury Attorneys is to support local organizations that positively impact our local communities.

ER Injury Attorneys has actively supported the Candlelighters Childhood Cancer Foundation of Southern Nevada’s annual Superhero 5K for over a decade. For 2022, the Las Vegas law firm is honored to once again show its support as a major sponsor of the Candlelighters Superhero 5K. The fun-run and walk takes place on September 17th at Exploration Park at Mountain’s Edge (9700 S Buffalo Dr., Las Vegas, 89178) at 8:00 a.m. and directly benefits the children and families served by the foundation.

In addition to sponsoring the 5K fun-run and 1 mile walk, team members from ER Injury Attorneys are hosting an event booth to give away chilly snow cones and more.

“One of the highest priorities of our team is to support local organizations that positively impact our local communities. Candlelighters is such an organization. The invaluable emotional and medicinal support it offers goes a long way to ease the hardships families face when battling childhood cancer,” stated founding attorney Corey Eschweiler.

Interested in joining the law firm in giving back to help raise life-saving funds for the Candlelighters Childhood Cancer Foundation of Southern Nevada? Register or make a donation online now. You can also email Info@CandleLightersNV.org or call (702) 737-1919 or to find out even more about the Candlelighters Superhero 5K.

More About ER Injury Attorneys

Helping Southern Nevada injury victims put their lives back on track after an accident is a top priority of the legal team at ER Injury Attorneys. In fact, their award-winning lawyers have built a reputation for providing the highest level of service by taking the time to listen, learn, and evaluate the needs of those who contact their law firm. This attention to detail not only promotes a positive and open collaboration, but also a higher success rate in terms of negotiating the best possible results. For more information about ER Injury Attorneys and their dedication to serve and assist local community members, please visit erinjuryattorneys.com or call 702-878-7878.

###

Share article on social media or email:

Debut Launches its Bio2Consumer™ Platform to Become the Leader in Vertically Integrated Synthetic Biology


“For synthetic biology to have a true impact on humanity, it needs to be commercialized, integrated into global supply chains, and ultimately embraced by consumers.” – Debut CEO Joshua Britton

Debut, an innovation company at the forefront of advanced biomanufacturing and consumer products, announced today a rebrand and new vision for next-generation consumer products by way of vertically integrated biology. Over the past three years, Debut has built the infrastructure to quickly move from ingredient discovery to sustainable consumer products. Debut uses breakthrough biotechnology and creativity to build big businesses that will put humanity ahead in an ever-changing world.

Traditional synthetic biology companies have pursued horizontal approaches, licensing, and low-margin B2B business structures that create unpredictable revenue streams and difficulties in penetrating global supply chains. The result is an inability to deliver products containing better ingredients that consumers demand, move past R&D, and generate the revenue streams required for sustained growth and longevity.

Debut’s proprietary Bio2Consumer™ platform enables the company to move rapidly from ingredient discovery to personal care and nutrition consumer products. The platform enables high throughput ingredient discovery, rapid testing, biomanufacturing, product formulation, pre-clinical testing, and on-site scaled manufacturing to deliver high-performing, natural, and sustainable consumer products. The result is a 98% reduction in testing cost and a 50% reduction in time-to-market compared to traditional horizontal companies.

According to a recent report, more than 58% of consumers across all generations are willing to spend more on sustainably manufactured products. As they become a larger buying force in the market, 90% of Gen X consumers would be willing to spend more for these types of products. With Debut’s approach, consumers need not choose between sustainability, performance, and cost.

“Our rebrand represents the next stage in synthetic biology. For synthetic biology to have a true impact on humanity, it needs to be commercialized, integrated into global supply chains, and ultimately embraced by consumers,” said Debut CEO Joshua Britton. “Consumers have been subjected to the same ingredients for years and typical marketing and greenwashing tactics have become the norm for larger, multinational corporations. It’s time to deliver high-performing products in high demand in multiple verticals. Our vertically integrated approach allows us to make an impact in a way that no other synthetic biology company has been able to achieve. We are creating consumer brands that will impact our routines from the time we wake up, get ready for work, and feed our animals to when we eat, exercise, and sleep. We see a future where synthetic biology-driven products are a norm for society and petroleum-derived products are long gone.”

Debut will launch its first brand next year and has the next set of high-growth brands in development. The company is creating sustainable and clinically proven consumer products that will become the next generation of household name brands, powered by Debut’s proprietary actives. The company can achieve this through the integration of next-generation biomanufacturing technology with a human-centered design approach that delivers efficiency to market and a real impact on consumers’ health and well-being. Joshua states, “We are eying significant US household penetration targets and the globalization of synthetic biology driven products. Think about what Unilever did during the chemical revolution in 1930 — we are doing that with biology.”

The company is currently building end-to-end manufacturing infrastructure and will continue to expand its Innovation Labs in San Diego, New York, Los Angeles, and Atlanta over the next several years. To learn more about Debut and its vertically integrated approach, visit http://www.debutbiotech.com.

Debut

Debut uses science, strategy, and creativity to build big businesses that put humanity ahead. Powered by breakthrough biotechnology and human-centered brand innovation, our integrated creation model sets the pace for an ever-changing world. For more information see https://www.debutbiotech.com/.

Share article on social media or email:

New Study Shows the Power of Reading First-Hand Stories in Reducing Suicidal Thoughts


Visual summary of scientific paper about use of bibliotherapy as an intervention for suicide prevention

Visual Summary of Digital Bibliotherapy as a Scalable Intervention for Suicidal Thoughts: A Randomized Controlled Trial

The new study assessed whether reading other people’s first-hand stories about working through suicidal thoughts online via The Mighty – digital narrative-based bibliotherapy – could reduce the desire to die among people with STB.

Social media is often criticized as harmful to mental health. But new research shows that reading one story a day online, written by someone with lived experience managing suicidal thoughts, can reduce suicidal thoughts and behaviors (STB) in the reader. The research was conducted by experts at Montefiore-Einstein, Harvard University and The Mighty, an online community that connects people facing health challenges. Findings from the research, “Digital Bibliotherapy as a Scalable Intervention for Suicidal Thoughts: A Randomized Controlled Trial,” were published in the peer-reviewed Journal of Consulting and Clinical Psychology.

Bibliotherapy is a therapeutic approach in which a planned reading program facilitates the recovery of patients living with mental illness or emotional disturbance.#_ftn1 [[1]] The new study assessed whether reading other people’s first-hand stories about working through suicidal thoughts online via The Mighty – digital narrative-based bibliotherapy – could reduce the desire to die among people with STB.

Results showed that participants who received the bibliotherapy intervention reported modest but statistically significantly lower STB, relative to those on a waiting list for the therapy. Further, these benefits were found to be explained in part by higher feelings of shared experience and optimism among those who received the therapy.

Suicide is the 10th leading cause of death in the United States – and the second leading cause among ages 25-34 – but there are few effective ways to alleviate STB. Many interventions lack accessibility and affordability, but digital bibliotherapy could be accessible for many, crossing income, education and geographic barriers.

“What we’ve learned gives us a new line of attack in this long-standing public health crisis: an easy way to address key psychological factors, such as loneliness and hopelessness, that lead people to think about ending their lives,” said study lead Dr. Peter J. Franz of Montefiore Medical Center, and the lead author of the paper. “It takes 10 minutes or less each day to read a story, yet digital narrative-based bibliotherapy makes a measurable difference, which may have a protective effect against STB. This could be layered into complementary therapies. And it’s as highly scalable as the internet, able to reach millions of people simply and cost-effectively.”

While this research shows the power of reading stories online in helping people with STB, future research could explore if this approach is effective in addressing other health issues shaped by similar factors.

“Bibliotherapy is well-established as a way to treat psychological distress, but this was the first randomized controlled trial of digital narrative-based bibliotherapy for those struggling with STB – and the first using content generated organically by users,” said Dr. Matt Nock, Chair of Harvard’s Department of Psychology and one of the world’s leading experts on suicide. “This is a potentially important piece in the suicide-prevention puzzle. And – because mental health impacts overall health and vice-versa – these findings may be useful in addressing a broad range of conditions, particularly those involving feelings of isolation or hard-to-discuss subject matter.”

The study was conducted using narratives from The Mighty, an online community that fosters conversations between people facing health issues and their peers, who share their experiences, expertise and relevant content.

Each day for 14 days, 266 study participants were asked to read one first-person account of working through suicidal feelings posted by community members on The Mighty. These participants recorded the impact this had on their desire to end their life. As a control, a group of 262 people who did not read stories also recorded their feelings of STB over the same period.

Results were compiled at the end of the study and after a two-week follow-up period. Key findings showed that:

  • The study group, which read the online narratives, reported no change in their desire to die during the first two weeks of the study, while the control group reported a statistically meaningful increase in STB.
  • These findings were sustainable: Study participants also reported significantly lower desire to die at the two-week follow-up than did those in the control group.
  • Results also were highly repeatable. Once members of the control group subsequently were offered bibliotherapy, they also reported a significantly lower desire to end their lives, mirroring the results of the initial study group almost exactly.
  • Participants who read narratives daily self-reported a lessened desire to die than those who read sporadically.

The research team also investigated reasons that the initial therapy group self-reported maintaining their levels of STB and found that this group reported higher feelings of shared experience and optimism during the trial than those in the control group.

“This study validates our belief that when people get the support and information they need they’re better equipped to help improve health outcomes. That’s what makes The Mighty work so well,” said Mike Porath, Founder and CEO of The Mighty. “But it also signals where we go from here: If feelings of shared experience and optimism work for people with STB, then digital bibliotherapy also may work for people with chronic pain, issues particularly relevant to the LGBTQIA+ community or any health challenge where isolation, stigma or the need for interaction are factors. This is only the beginning, and the possibilities are exciting.”

The Mighty was founded in 2014 by Porath and his wife, whose experience with their daughter’s rare disease diagnosis sparked the idea to create a network where people could come together to discuss common health issues and exchange information, expertise, advice and experiences. Today, in addition to its 3.5 million members, the community also is home to partnerships with leading health and wellness companies, all sharing the goal of driving better health outcomes.

About the Study

The study involved 528 adults visiting a social media platform for mental health support. Participants were randomized to a treatment condition (n=266), in which they read one suicide narrative per day for 14 days, or to a waitlist control condition (n=262). The desire to end their lives was assessed daily for the 14-day trial period and during a two-week follow-up.

About The Mighty

The Mighty is a healthcare company and unique online community that empowers people to better manage their health challenges and disabilities through social connectedness. More than 3.5 million registered users regularly share first-hand stories, experiences and insights to help each other navigate medical situations and address real-world issues they face across more than 700 health conditions. Insights shared in the site’s forums also help The Mighty’s healthcare partners better understand community members’ actual experiences, so they can learn how better to serve them. More information can be found at https://corp.themighty.com/ and on LinkedIn, Twitter, Instagram and Facebook.

[[1]] https://www.ala.org/tools/atoz/bibliotherapy

Share article on social media or email:



Prescriptive Capital, Saber Street and CBK Interests Announce Medical Office Development in The Woodlands, Texas


Prescriptive Capital, a Denver-based real estate private equity firm, and Houston-based healthcare developers Saber Street and CBK Interests have announced their plans to begin the initial development phase of a 45,000 square foot medical office building in The Woodlands, Texas.

The building is 80% pre-leased to a large physician practice group that has made a long-term commitment to the building and to serving the surrounding community. The site is located on the heavily trafficked Kuykendahl Road, just south of Carlton Woods at Creekside – one of the wealthiest residential enclaves in The Woodlands with median home pricing currently exceeding $1.5 million.

The three-story building will be developed on a 4.685-acre lot. Arch-Con Corporation has been selected as the general contractor and groundbreaking for the development is scheduled for December 2022.

“Creekside Park is one of the fastest-growing markets in The Woodlands, Texas, and it is underserved from a healthcare perspective,” said Chris Haley, Co-Founder and Managing Partner of Saber Street. “Pre-leasing on this building will bring a variety of critical healthcare providers and services to the growing community.”

“We are incredibly excited to partner with the Saber Street and CBK Interests team on this development,” said Chris Bodnar, CEO of Prescriptive Capital. “This project will be a significant and positive contribution to the community, and we’re grateful to be working alongside some of the best healthcare developers in Texas.”

###

About Prescriptive Capital

Prescriptive Capital is a private equity firm focused exclusively on investing in alternative real estate investment sectors. With more than 60 years of combined experience in commercial real estate, Prescriptive Capital’s principals have developed a distinct strategy rooted in data analytics that guides an investment approach with unrivaled precision. Prescriptive Capital sources the most resilient alternative real estate investment opportunities with limited correlation and maximum resistance to greater economic trends, allowing investors to further diversify their portfolio and enjoy favorable risk-adjusted returns across market cycles.

For more information on Prescriptive Capital, please visit

https://www.prescriptivecap.com

About Saber Street & CBK Interests

Saber Street is a boutique, full-service commercial real estate company based in Houston, Texas specializing in the sponsorship, development, ownership and operation of healthcare assets. Its principals have owned, developed, leased or managed over 2.9 million square feet and completed over $2.0 billion in principal and service-related transactions in their careers. Focused on transforming trusted relationships into strategic partnerships, Saber Street utilizes its expertise, experience and creativity in the field to collaborate with investors, physicians, ancillary service providers and health systems on their real estate requirements.

For more information, please visit https://www.saberstreet.com.

CBK Interests is a boutique real estate company based in Houston, Texas founded in 2014 by Cullen Kappler. CBK Interests specializes in the development, acquisition, and investment opportunities in commercial real estate.

Share article on social media or email:

Russell and Dawson Inc. and AORBIS Inc. Donate PPE Supplies to Jamaican Health System through Collaboration with Hartford HealthCare


(L to R) Chris Benjamin, Bimal Patel, Chirag Thaker, Tanmay Thaker

“We shared the need of PPE supplies with local businesses, we are so grateful to leadership of Chirag Thaker & Jalpa Thaker in making this donation to Jamaican Healthcare System,” said Bimal Patel, President of Hartford Hospital and Senior Vice President, Hartford HealthCare.

Russell and Dawson Inc., an A/E/C firm and AORBIS Inc., the supplier of building products donated more than US$550,000 worth PPE supplies to Jamaican Health System through collaboration with Hartford HealthCare. The donation includes KN-95 masks, 3-ply masks, gloves, gowns and hand sanitizer — items which are still in great need in Jamaica.

Hartford HealthCare has forged a strong partnership with the Jamaican Health System since the start of the pandemic by facilitating donation of equipment & supplies and exchange of technology and information. “We shared the need of PPE supplies with local businesses, we are so grateful to leadership of Chirag Thaker & Jalpa Thaker in making this donation to Jamaican Healthcare System,” said Bimal Patel, President of Hartford Hospital and Senior Vice President, Hartford HealthCare.

“With the on-going pandemic, we were looking to donate PPE kits where they would be most valuable and useful. After learning about this excellent opportunity from Keith Grant, Sr. System Director for Infection Prevention at Hartford Healthcare, we decided to support the Jamaican Health System by making a contribution for the benefit of an island” said Chirag Thaker, President, Russell and Dawson Inc. and AORBIS Inc.

Chris Benjamin, Community Relations Officer for the Jamaican Consulate in New York City said “This donation will go a long way in alleviating the difficulties we are still having in Jamaica because of the pandemic. These PPE will be distributed to several hospitals on the island. It will help ensure there is an adequate supply of PPE, especially in the areas of greatest need,”

Here are few community involvements of Russell and Dawson Inc. and AORBIS Inc.


  • Russell and Dawson Inc. and AORBIS Inc. donated 25,000 K95 masks and 10,000 hand sanitizers to Community Renewal Team Inc., Anti-Poverty mission to aid people in Central Connecticut.
  • Russell and Dawson Inc. provided Pro-Bono Structural Design Services for Growing Spaces Growing Dome®, a greenhouse project for Community Child Guidance Clinic (CCGC).
  • Russell and Dawson Inc. has offered architectural design services either pro-bono or at minimal rates to more than 15 Animal Shelter Projects, 70 Worship Places (Churches, Temples, Mosques), 5 local Community Centers (Christian, Jewish, Islamic)


Read more about PPE supplies donation here : https://www.rdaep.com/news/russell-and-dawson-inc-and-aorbis-inc-donate-ppe-supplies-to-jamaican-island-through-hartford-healthcare/

About Russell and Dawson Inc. (https://www.rdaep.com):

Russell and Dawson is a client-1st architectural design, engineering and construction services firm based out of Hartford, Connecticut. Since 1965, Russell and Dawson has completed more than 10,000 projects across various sectors in the northeast states.

LinkedIn Link – https://www.linkedin.com/company/rdaepct/

Facebook Link – https://www.facebook.com/rdaepct/

About AORBIS Inc. (https://www.aorbis.com):

Established in the year 2018, AORBIS Procures Building Products, Materials, and Services for Owners, and General Contractors in the United States.

LinkedIn Link – https://www.linkedin.com/company/aorbis-inc

Facebook Link – https://www.facebook.com/AORBISInc

About Hartford HealthCare (https://hartfordhealthcare.org):

With 33,000 colleagues, Hartford HealthCare’s unified culture enhances access, affordability, equity and expertise. Its care-delivery system — with more than 400 locations serving 185 towns and cities — includes two tertiary-level teaching hospitals, an acute-care community teaching hospital, an acute-care hospital and trauma center, three community hospitals, a behavioral health network, a multispecialty physician group, a clinical care organization, a regional home care system, an array of senior care services, a mobile neighborhood health program and a comprehensive physical therapy and rehabilitation network. On average, Hartford HealthCare touches more than 17,000 lives every single day. The unique, system-wide Institute Model offers a unified high standard of care in crucial specialties at hospital and ambulatory sites across Connecticut offering unparalleled expertise at the most affordable cost. The institutes include: Cancer, Heart and Vascular, Ayer Neuroscience, Orthopedics and Tallwood Urology. Visit Hartford HealthCare at http://www.HartfordHealthCare.org and stay connected through newsletters and social media.

Share article on social media or email:

DesignRush Best Design Awards Recognizes SEM Nexus For MIBit App Design


57% of users would never recommend a business with a bad mobile design. In fact, bad mobile experiences are the reason why 62% of users are less likely to purchase from these brands in the future, as pooled by Wilderness Agency.

DesignRush, a B2B marketplace connecting businesses with agencies, through its Best Design Awards program, recognizes SEM Nexus for its standout work on MIBit app design.

The app design for MIBit, a peer-to-peer borrowing marketplace, relies on a simplistic design and strong user experience to facilitate fast and transparent transactions.

The award-winning agency opted for “to-the-point” design over flashy aesthetics, yet it created an appealing app that connects sellers and buyers swiftly, efficiently and conveniently.

Key design highlights include:

  • Usage of on-brand lime green color to ensure user attention
  • Carefully chosen typography that accelerates usability
  • Simple and to-the-point messaging
  • Plenty of white space for a cleaner look
  • A well-planned visual hierarchy

Explore the full design and expert analysis here.

You can also submit your best designs for a chance to be featured on DesignRush.

About DesignRush:

DesignRush.com is a B2B marketplace connecting businesses with agencies through expert reviews and agency ranking lists, awards, knowledge resources and personalized agency recommendations for vetted projects.

Share article on social media or email:

Dennis Quaid to host upcoming Viewpoint segment on Infant Safety


News Image

Staying up-to-date on what items can pose a threat and ensuring any harmful items are out of reach or locked away can go a long way in protecting little ones.

The “Viewpoint” program will be highlighting infant safety tips with leading industry experts across the medical fields as well as other applicable sectors. The show will cover essential information for parents and guardians to protect little ones from harm. Viewpoint with Dennis Quaid’s developers worked closely with experts in infant care to create the episode.

Baby safety practices are essential for keeping loved ones safe. Many infants are injured yearly due to unsafe devices, toys, or environments. From car seats to homes, there are several devices, and tips parents and guardians can incorporate to ensure the safety of the infants in their care. Staying up-to-date on what items can pose a threat and ensuring any harmful items are out of reach or locked away can go a long way in protecting little ones.

Some tips include feeding only soft, easy-to-swallow foods. Don’t shake or toss a baby in the air. Keep an eye out for broken toys – any broken small pieces could be ingested and cause an obstruction. Use baby gates to keep small ones out of pools, away from sharp objects, and rooms with exposed electrical outlets or stairs. Investing in quality baby equipment can be helpful as hand-me-downs may not be in the best shape and may pose safety concerns.

Children grow rapidly, as do their needs, and viewers can learn more about infant safety in the upcoming episode on Viewpoint. Dennis Quaid will open and close the segment.

Viewpoint is an educational documentary series. The program is the recipient of numerous awards for its efforts in educational television.

Share article on social media or email:

Dr Kingsley R Chin steps down as CEO of NanoFuse Biologics LLC after merger with NANISX LLC


NanoFuse Biologics LLC merges its unique innovations in synthetic biologics with NANISX LLC

NanoFuse Biologics represents the most unique and innovative advance in synthetic biologics in recent years.

NanoFUSE Biologics is the world’s only FDA-approved synthetic fiber-based bioactive glass combined with demineralized bone matrix (DBM) for regenerative bone formation, promoting fusion and bone healing. NanoFUSE, when combined with an aqueous body fluid, forms a 3D ultra porous calcium hydroxyapatite layer for bone formation in as early as 24 hours. This reaction leads to the immediate release of Calcium, Sodium, Silica and Phosphate ions and the angiogenic/osteogenic response. Healthcare investment firm focused on ambulatory surgery center (ASC) spine surgery, KICVentures Group, owns NanoFuse Biologics LLC, Inspan LLC and Sacrix LLC and merged its holdings into NANISX LLC as of August 15th, 2022.

NanoFUSE is positioning to build a dedicated team, expand its market share of the over $5 billion orthobiologics market, and challenge Stryker’s Vitoss BA bioactive glass, the top-selling synthetic biologic. This goal made it compelling for NanoFUSE to decide to merge with NANISX LLC and prepare for an IPO to raise capital as a combined offering with InSpan and Sacrix as complimentary products with large total addressable markets across Interventional Pain Management (IPM), Orthopedic surgeons and Neurosurgeons.

Synthetic biologics use is becoming more prevalent as pressures are placed on human tissue and the reimbursement for human allografts is declining. Bioactive glass has proven efficacy and is readily available to be made cost-effectively with reduced lead times and large quantities. Stryker Spine acquired Vitoss for approximately $300 million in 2011 and built it into the #1 selling synthetic biologics business. Johnson & Johnson’s Depuy acquired Prosydian bioactive glass after a four-year distribution arrangement signalled the need for the acquisition.

“NanoFUSE Biologics is unique in having its own patented manufacturing process for its micro-spherical fiber-based bioactive glass that can be shaped into any formulation for various applications in spine surgery, orthopedics, dental and craniofacial surgery,” says board-certified orthopedic spine surgeon, Dr Kingsley R Chin.

NanoFUSE Putty has a five-year shelf life and is sterile packaged, so it is easy to ship and store in large quantities anywhere in the USA or internationally. “NanoFUSE Biologics has been showing steady organic revenue growth since being acquired by the KICVentures Group in 2018 and is poised for accelerated commercialization as more doctors adopt InSpan and Sacrix in ASCs and pull-through NanoFUSE as a compliment to the devices,” says CFO, Aditya Humad.

Bioactive glass is going to be a significant factor in the future of synthetic biologics with its flexible forms and effectiveness. NANISX technology platform has been revenue and EBITDA positive and should grow rapidly with the expected addition of a new Chief Executive Officer (CEO) to be announced soon. We have initiated the listing process to prepare for an IPO with a New York-based advisory firm including the search for the right governance to establish processes to scale and be ready within 12 to 18 months.

INVESTOR

Series A Now open in KICVentures Group.

INVESTOR@kicventures.com.

About NanoFUSE Biologics LLC

NanoFUSE Biologics LLC is privately owned by the KICVentures Group and has a proprietary fiber-based synthetic bioactive glass. NanoFUSE is the only FDA-approved combination of bioactive glass plus DBM and is proven for regenerating bone.

http://www.Nanofusebiologics.com

About KICVentures Group

Founded in 2000 makes us the most experienced healthcare investment holding company with the largest portfolio of medical device technologies focused on solutions for less invasive outpatient spine surgery. Our investment strategy is to acquire or invent disruptive technologies using our own capital or partner with private individual investors. This allows us the freedom to make quick and nimble decisions such as when we acquired AxioMed Viscoelastic Disc Technologies while other rms invested in ball-and-socket articulating spacers.

http://www.KICVentures.com

Share article on social media or email:

Author Tracy Peay’s new book “I’m Still Here” is a searing memoir of his family’s struggles with addiction and his journey toward recovery with the help of his faith


News Image

Tracy Peay, a survivor born into a family of eight in a small town in northern Utah, has completed his new book “I’m Still Here: A Glimpse into My Life as a Drug Addict and My Journey Back through Christ”: a heart-wrenching autobiography about a family devastated by intractable addiction and the author’s own path toward healing and recovery.

The author shares, “This author has been through the valley of the shadow of death. When I chose to use illegal drugs, I lost. I lost my whole family to drugs, except for my dad. I lost my jobs, my marriages, my children; I lost two brothers (from drug overdoses and alcohol poisoning), and my mom died of transverse myelitis all within a six-month period. I lost a nephew a few years later (from a drug overdose).

When you choose illegal drugs, you choose death—death of body and spirit. Your life will look like a battlefield with bodies of your friends and family strewn about. I lost my dignity and self-respect and nearly my own life many times. I thought the only answer to every problem was suicide. If I got arrested, I took pills to try to overdose; if I had a conflict with anyone, I tried to kill myself. Even if I had a toothache, I tried to slit my wrists. I did die several times but was revived. I ran from the law, was arrested, and spent time in jail several times. I lost my apartments and became homeless.

You would think God was not with me during these dark times, but He was. I called on Him many times through prayer, and He was always there. Satan was with me also, and I felt shear evil when I saw Satan face-to-face once. But I also felt unspeakable joy when I saw Jesus Christ face-to-face. It was a hard journey to find Christ, but I read my scriptures, studied, and prayed. Remember, “I can do all things through Christ who strengthens me” (Philippians 4:13). And know that you are a “child of God”—a child of a King—and you have royal blood running through your veins. The worth of your soul is great. Jesus Christ is your shepherd, and He goes after lost sheep and brings them back to His fold. He may not come in person to save you, but He will send someone, as he did for me. Nathan, working with the bishop of our church, was the man (my personal angel) who took me off the streets when I was homeless. I will ever be grateful.

I believe ‘I’m Still Here’ because Christ wants me to teach others what I have learned about the destruction that comes to you when you make drugs the center part of your life instead of Christ. I can tell you that the only way back from addiction to drugs is through Jesus Christ.”

Published by Page Publishing, Tracy Peay’s engrossing book is an inspiring true story of perseverance, hope, and faith throughout an extraordinary life journey.

The author’s wish is that his book be used for good. He would like every parent, grandparent, and spouse to have his book in their bookcase to hand out to anyone who is considering doing illegal drugs or wants to come back from addiction. Young kids are making their choice to use drugs and alcohol as young as 9 years old – the age that the author was introduced to drugs. He would like his book to go into jails and prisons and to be used by counselors and in 12-Step programs.

Readers who wish to experience this engaging work can purchase “I’m Still Here: A Glimpse into My Life as a Drug Addict and My Journey Back through Christ” at bookstores everywhere, or online at the Apple iTunes Store, Amazon, Google Play, or Barnes and Noble.

For additional information or media inquiries, contact Page Publishing at 866-315-2708.

About Page Publishing:

Page Publishing is a traditional, full-service publishing house that handles all the intricacies involved in publishing its authors’ books, including distribution in the world’s largest retail outlets and royalty generation. Page Publishing understands that authors should be free to create, not mired in logistics like eBook conversion, establishing wholesale accounts, insurance, shipping, taxes, and so on. Page’s accomplished writers and publishing professionals allow authors to leave behind these complex and time-consuming issues and focus on their passion: writing and creating. Learn more at http://www.pagepublishing.com.

Share article on social media or email:

Early Bird Price Ending in 1 Week for WCG MAGI Clinical Research Conference 2022 West


WCG MAGI Clinical Research Conference 2022 West

Oct. 16-19, 2022

Planet Hollywood Las Vegas Resort & Casino, Las Vegas, NV

https://wcg.swoogo.com/MAGI-West

WCG MAGI conferences are the best value in clinical research. Which is why attending WCG MAGI Clinical Research Conference 2022 West makes great business sense, giving clinical trial professionals the actionable information and connections needed to enhance their clinical trials.

And right now, save up to $200 off. Early Bird pricing ends on Sept. 16, 2022.

Attendees choose from more than 70 sessions addressing the biggest clinical trial issues. After past conferences participants returned to their organization with an average of 10 practical tips they implemented for better clinical trials.

Whether they are from a sponsor, research site or CRO, a newcomer to the industry, a senior executive or somewhere in between, attendees will find what they need at WCG MAGI West, including:


  • Ensuring Appropriate Representation in Clinical Trials to Advance Medicine and Reduce Health Disparities


Design practical, proactive diversity plans that better advance excellence in clinical research with this session. The session includes a discussion of the FDA’s recent draft guidance on clinical trial diversity plans and the work being done to promote health equity and reduce health disparities through the clinical research enterprise within the FDA’s Office of Minority Health and Health Equity.

  • A Pro/Con Debate: Clinical Trials “as a Care Option”


In this session, two speakers debate whether the current trend of referring to “clinical trials as a care option” is a positive statement that reinforces that research participants should be offered to all patients as part of medical care or a statement that inappropriately blurs the line between medical care and clinical research, creating a therapeutic misconception.

  • Keynote by Mary Elizabeth Williams, On the Importance of Clinical Research: A Patient’s Perspective


This patient advocate, journalist, and health and science writer — also a stage IV melanoma survivor thanks to the Phase 1 immunotherapy clinical trial that saved her life — will discuss the importance of strong healthcare communication in the clinical trial setting. A doctoral candidate in Medical Humanities at Drew University, she’ll share how collaborative, empathetic techniques can improve enrollment, retention and outcomes.

  • The Best Professional Networking Anywhere


WCG MAGI conferences are all about lasting relationships. Throughout the four-day event, facilitated peer-to-peer networking will help participants meet people from all areas of the clinical research industry and strengthen existing relationships.

WCG MAGI Clinical Research Conference 2022 West will empower participants to take their clinical trials to the next level. Register by Sept. 16 to get the Early Bird savings.

Conference Details:

WCG MAGI Clinical Research Conference 2022 West

Oct. 16-19, 2022

Planet Hollywood Las Vegas Resort & Casino, Las Vegas, NV

https://wcg.swoogo.com/MAGI-West

Price:

All-Access Pass:

Early Bird: Register by Sept. 16, 2022 — $1,295

After Sept. 16, 2022 — $1,495

Includes all workshops, panel discussions, sessions, meals and exhibit hall access.

Preconference Workshops Only Pass – $345.00

Includes access to the preconference workshops on Sunday only. Lunch is included.

Exhibit Hall Only Pass – $125.00

Includes access to the exhibit hall only. Lunch is not included.

Easy Ways to Register:

Online: https://wcg.swoogo.com/MAGI-West

By phone: 888.838.5578 or 703.538.7600

About WCG MAGI Conferences:

WCG MAGI events connect clinical research professionals who share a deep commitment to ensuring the quality, compliance, and efficiency of clinical research that is needed to advance the delivery of therapies and devices that impact patient’s lives. Professionals who attend WCG MAGI conferences benefit from: comprehensive programing including best-in-class training from seasoned faculty; standardization of best practices for clinical operations, business, and regulatory compliance; innovation forums; and peer-to-peer networking. Most importantly, the WCG MAGI experience strengthens collegiality in a way that ensures the growth and success of clinical research.

Share article on social media or email: